UNSPSC 51281816: Daunorubicin aglycone

This classification denotes an anthracycline antibiotic with the molecular formula C21H18O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FN5680X78X, chemically known as 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8s,10s)-, but more generally known as daunorubicin aglycone, which bears US NIH Compound Identifier 83843. European Medicines Agency schedules daunorubicin aglycone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06917MIG.

Most nations, for tariff purposes, schedule daunorubicin aglycone under HS 29419000. SMILES: CC(=O)[C@@]1(CC2C(C(C3C(C2O)C(=O)C4CCCC(C4C3=O)OC)O)[C@H](C1)O)O.

UNSPSC 51281816 Daunorubicin aglycone is a Commodity code that nominally describes a specific pharmaceutical compound, yet recent state and local opportunities tagged to this code do not reflect purchases of daunorubicin itself. Instead, the tagged solicitations cover broader pharmaceutical supply and public health product procurement — including antibiotic tablets, naloxone, and drug deactivation systems — suggesting either taxonomic misalignment in how state and local procurement offices classify pharmaceutical buys or that the code serves as a catch-all for emergency pharmaceutical and related health-product procurement. State and local issuing bodies using this code include state health departments and county government public health offices; Illinois Department of Public Health and Seminole County, Florida appear in recent activity.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (IFB 26482DPHPREPDB53392, closed) for $2,999,999.11 over the life of the contract, supplying antibiotic tablets with an initial 12-month term and two renewal options. Seminole County, Florida released an IFB on June 30, 2026 (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, under a two-year initial term with one-year renewal option. Both procurements emphasize electronic bid submission, compliance with drug-free workplace and E-Verify requirements, and fixed-fee pricing structures.